@inproceedings{inproceedings, title  = {{A cost-utility analysis of nilotinib for CML patients who have become resistant to imatinib.}},

 url = {{}},

 year = {{2007}},

 month = {{11}},

 author = {{Pilgrim H and Jewitt K and Ward S}},

 volume = {{110}},

 journal = {{BLOOD}},

 issue = {{11}},

 pages = {{376B-376B}},

 note = {{Accessed on 2024/12/21}}}